Excess dosing of antithrombotic therapy in non-ST-segment elevation acute coronary syndromes

JAMA. 2006 Apr 26;295(16):1896; author reply 1897. doi: 10.1001/jama.295.16.1896-a.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angina, Unstable / drug therapy*
  • Anticoagulants / administration & dosage
  • Anticoagulants / adverse effects
  • Antithrombins / administration & dosage*
  • Antithrombins / adverse effects*
  • Hemorrhage / etiology
  • Heparin / administration & dosage
  • Heparin / adverse effects
  • Heparin, Low-Molecular-Weight / administration & dosage
  • Heparin, Low-Molecular-Weight / adverse effects
  • Humans
  • Partial Thromboplastin Time
  • Platelet Aggregation Inhibitors / administration & dosage
  • Platelet Aggregation Inhibitors / adverse effects
  • Risk

Substances

  • Anticoagulants
  • Antithrombins
  • Heparin, Low-Molecular-Weight
  • Platelet Aggregation Inhibitors
  • Heparin